Novo Holdings A/S bought MGX

February 9, 2024 · Form 4 insider transaction

Novo Holdings A/S bought 100,000 shares of Metagenomi Therapeutics, Inc. at $10.25 per share, a transaction worth $1.02M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 6 days after the transaction.